{"id":"https://openalex.org/W2892004169","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.9000","title":"Inter- and intra-patient heterogeneity of resistance mechanisms to the mutant EGFR selective inhibitor rociletinib.","display_name":"Inter- and intra-patient heterogeneity of resistance mechanisms to the mutant EGFR selective inhibitor rociletinib.","publication_year":2016,"publication_date":"2016-05-20","ids":{"openalex":"https://openalex.org/W2892004169","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.9000","mag":"2892004169"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2016.34.15_suppl.9000","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.9000","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2016.34.15_suppl.9000","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076624501","display_name":"Jacob J. Chabon","orcid":"https://orcid.org/0000-0003-1820-9737","observed_orcids":["https://orcid.org/0000-0003-1820-9737"]},"institutions":[{"id":"https://openalex.org/I4394709089","display_name":"Institute for Stem Cell Biology and Regenerative Medicine","ror":"https://ror.org/02vbab064","country_code":null,"type":"facility","lineage":["https://openalex.org/I4210137306","https://openalex.org/I4394709089","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacob J. Chabon","raw_affiliation_strings":["Institute for Stem Cell Biology and Regenerative Medicine, Stanford, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Stem Cell Biology and Regenerative Medicine, Stanford, CA;","institution_ids":["https://openalex.org/I4394709089","https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103133276","display_name":"Andrew D. Simmons","orcid":"https://orcid.org/0000-0001-6075-0549","observed_orcids":["https://orcid.org/0000-0001-6075-0549"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew Simmons","raw_affiliation_strings":["Clovis Onc, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clovis Onc, San Francisco, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002498799","display_name":"Aaron M. Newman","orcid":"https://orcid.org/0000-0002-1857-8172","observed_orcids":["https://orcid.org/0000-0002-1857-8172"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron M. Newman","raw_affiliation_strings":["Division of Oncology, Stanford University School of Medicine, Stanford, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Oncology, Stanford University School of Medicine, Stanford, CA;","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079914472","display_name":"Alexander F. Lovejoy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexander F. Lovejoy","raw_affiliation_strings":["Roche Molecular Systems, Pleasanton, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Molecular Systems, Pleasanton, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013352965","display_name":"Mohammad Shahrokh Esfahani","orcid":"https://orcid.org/0000-0002-0950-3937","observed_orcids":["https://orcid.org/0000-0002-0950-3937"]},"institutions":[{"id":"https://openalex.org/I4390039303","display_name":"Stanford Cancer Institute","ror":"https://ror.org/014qe3j22","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I4390039303","https://openalex.org/I97018004"]}],"countries":[],"is_corresponding":false,"raw_author_name":"Mohammad S Esfahani","raw_affiliation_strings":["Stanford Cancer Institute, Stanford, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stanford Cancer Institute, Stanford, CA;","institution_ids":["https://openalex.org/I4390039303"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048447647","display_name":"Henry J. Haringsma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151488","display_name":"Clovis Oncology (United States)","ror":"https://ror.org/04ps4d441","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151488"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Henry Haringsma","raw_affiliation_strings":["Clovis Oncology Inc, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clovis Oncology Inc, San Francisco, CA;","institution_ids":["https://openalex.org/I4210151488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068290727","display_name":"David Matthew Kurtz","orcid":"https://orcid.org/0000-0002-6382-4651","observed_orcids":["https://orcid.org/0000-0002-6382-4651"]},"institutions":[{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Matthew Kurtz","raw_affiliation_strings":["Stanford University, Palo Alto, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stanford University, Palo Alto, CA;","institution_ids":["https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051565478","display_name":"Henning Stehr","orcid":"https://orcid.org/0009-0002-1628-9171","observed_orcids":["https://orcid.org/0009-0002-1628-9171"]},"institutions":[{"id":"https://openalex.org/I4390039303","display_name":"Stanford Cancer Institute","ror":"https://ror.org/014qe3j22","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I4390039303","https://openalex.org/I97018004"]}],"countries":[],"is_corresponding":false,"raw_author_name":"Henning Stehr","raw_affiliation_strings":["Stanford Cancer Institute, Stanford, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stanford Cancer Institute, Stanford, CA;","institution_ids":["https://openalex.org/I4390039303"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057483013","display_name":"Florian Scherer","orcid":"https://orcid.org/0000-0001-9635-5487","observed_orcids":["https://orcid.org/0000-0001-9635-5487"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Florian Scherer","raw_affiliation_strings":["Division of Oncology, Stanford University School of Medicine, Stanford, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Oncology, Stanford University School of Medicine, Stanford, CA;","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009357275","display_name":"Kathleen A. Durkin","orcid":"https://orcid.org/0000-0003-1282-6101","observed_orcids":["https://orcid.org/0000-0003-1282-6101"]},"institutions":[{"id":"https://openalex.org/I95457486","display_name":"University of California, Berkeley","ror":"https://ror.org/01an7q238","country_code":"US","type":"education","lineage":["https://openalex.org/I95457486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kathleen A. Durkin","raw_affiliation_strings":["University of California Berkeley, Berkeley, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California Berkeley, Berkeley, CA;","institution_ids":["https://openalex.org/I95457486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004712121","display_name":"Gregory A. Otterson","orcid":"https://orcid.org/0000-0001-9877-8512","observed_orcids":["https://orcid.org/0000-0001-9877-8512"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory Alan Otterson","raw_affiliation_strings":["Ohio State University, Columbus, OH;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ohio State University, Columbus, OH;","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112394356","display_name":"W. Thomas Purcell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William T. Purcell","raw_affiliation_strings":["University of Colorado Cancer Center, Aurora, CO;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Colorado Cancer Center, Aurora, CO;","institution_ids":["https://openalex.org/I4210134151"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082517668","display_name":"D. Ross Camidge","orcid":"https://orcid.org/0000-0003-3430-3213","observed_orcids":["https://orcid.org/0000-0003-3430-3213"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Ross Camidge","raw_affiliation_strings":["University of Colorado, Aurora, CO;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Colorado, Aurora, CO;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036134937","display_name":"Jonathan Wade Goldman","orcid":"https://orcid.org/0000-0002-4925-8243","observed_orcids":["https://orcid.org/0000-0002-4925-8243"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I4390039293","display_name":"UCLA Jonsson Comprehensive Cancer Center","ror":"https://ror.org/0599cs764","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I4390039293"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan Wade Goldman","raw_affiliation_strings":["UCLA, Jonsson Comprehensive Cancer Center, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA, Jonsson Comprehensive Cancer Center, Los Angeles, CA;","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I4390039293"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075333926","display_name":"Lecia Van Dam Sequist","orcid":"https://orcid.org/0000-0002-8965-6991","observed_orcids":["https://orcid.org/0000-0002-8965-6991"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lecia V. Sequist","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069070706","display_name":"Zofia Piotrowska","orcid":"https://orcid.org/0000-0002-9008-8573","observed_orcids":["https://orcid.org/0000-0002-9008-8573"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zofia Piotrowska","raw_affiliation_strings":["Massachusetts General Hospital Cancer Center, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital Cancer Center, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035640724","display_name":"Heather A. Wakelee","orcid":"https://orcid.org/0000-0003-1136-980X","observed_orcids":["https://orcid.org/0000-0003-1136-980X"]},"institutions":[{"id":"https://openalex.org/I4390039303","display_name":"Stanford Cancer Institute","ror":"https://ror.org/014qe3j22","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I4390039303","https://openalex.org/I97018004"]}],"countries":[],"is_corresponding":false,"raw_author_name":"Heather A. Wakelee","raw_affiliation_strings":["Stanford Cancer Institute, Stanford, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stanford Cancer Institute, Stanford, CA;","institution_ids":["https://openalex.org/I4390039303"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034377849","display_name":"Joel W. Neal","orcid":"https://orcid.org/0000-0003-3119-9334","observed_orcids":["https://orcid.org/0000-0003-3119-9334"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I4390039303","display_name":"Stanford Cancer Institute","ror":"https://ror.org/014qe3j22","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I4390039303","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joel W. Neal","raw_affiliation_strings":["Stanford Cancer Institute/Stanford University School of Medicine, Stanford, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stanford Cancer Institute/Stanford University School of Medicine, Stanford, CA;","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I4390039303","https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007420876","display_name":"Ash A. Alizadeh","orcid":"https://orcid.org/0000-0002-5153-5625","observed_orcids":["https://orcid.org/0000-0002-5153-5625"]},"institutions":[{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ash A. Alizadeh","raw_affiliation_strings":["Stanford Comp Cancer Center, San Mateo, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stanford Comp Cancer Center, San Mateo, CA;","institution_ids":["https://openalex.org/I97018004"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001873561","display_name":"Maximilian Diehn","orcid":"https://orcid.org/0000-0003-2032-0581","observed_orcids":["https://orcid.org/0000-0003-2032-0581"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maximilian Diehn","raw_affiliation_strings":["Stanford University School of Medicine, Stanford, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stanford University School of Medicine, Stanford, CA;","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":11,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"34","issue":"15_suppl","first_page":"9000","last_page":"9000"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rociletinib","display_name":"rociletinib","score":0.9940000176429749},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.9430000185966492},{"id":"https://openalex.org/keywords/egfr-t790m-mutation","display_name":"T790M mutation","score":0.8450000286102295},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.7850000262260437},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9300000071525574},{"id":"https://openalex.org/keywords/circulating-tumor-dna","display_name":"circulating tumor DNA","score":0.9129999876022339},{"id":"https://openalex.org/keywords/met-amplification","display_name":"MET amplification","score":0.9070000052452087},{"id":"https://openalex.org/keywords/kras-mutation","display_name":"KRAS mutation","score":0.8289999961853027},{"id":"https://openalex.org/keywords/crizotinib","display_name":"crizotinib","score":0.7509999871253967},{"id":"https://openalex.org/keywords/tumor-heterogeneity","display_name":"tumor heterogeneity","score":0.6700000166893005},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7379999756813049}],"concepts":[{"id":"https://openalex.org/C2777930144","wikidata":"https://www.wikidata.org/wiki/Q25100112","display_name":"T790M","level":5,"score":0.8983173966407776},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7569433450698853},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.7419812083244324},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.7034388780593872},{"id":"https://openalex.org/C2779422266","wikidata":"https://www.wikidata.org/wiki/Q5186964","display_name":"Crizotinib","level":4,"score":0.6707668304443359},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.6141009330749512},{"id":"https://openalex.org/C182707283","wikidata":"https://www.wikidata.org/wiki/Q7315622","display_name":"Resistance mutation","level":5,"score":0.606762170791626},{"id":"https://openalex.org/C2777626846","wikidata":"https://www.wikidata.org/wiki/Q21506464","display_name":"Osimertinib","level":5,"score":0.5478231906890869},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5100923180580139},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.47503426671028137},{"id":"https://openalex.org/C2994294914","wikidata":"https://www.wikidata.org/wiki/Q1645075","display_name":"Acquired resistance","level":3,"score":0.4749603271484375},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.42291003465652466},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.41610971093177795},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.41334810853004456},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3951275646686554},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.31510746479034424},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.22593840956687927},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1990084946155548},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.16118648648262024},{"id":"https://openalex.org/C49105822","wikidata":"https://www.wikidata.org/wiki/Q176996","display_name":"Polymerase chain reaction","level":3,"score":0.13108140230178833},{"id":"https://openalex.org/C156719811","wikidata":"https://www.wikidata.org/wiki/Q28774","display_name":"Reverse transcriptase","level":4,"score":0.07242301106452942},{"id":"https://openalex.org/C2776232967","wikidata":"https://www.wikidata.org/wiki/Q6743514","display_name":"Malignant pleural effusion","level":3,"score":0.0},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2016.34.15_suppl.9000","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.9000","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2016.34.15_suppl.9000","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.8399999737739563,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2767471949","https://openalex.org/W3206265110","https://openalex.org/W2981762400","https://openalex.org/W3002825748","https://openalex.org/W2903740294","https://openalex.org/W2898298795","https://openalex.org/W4226483150","https://openalex.org/W4327498261","https://openalex.org/W4322500515","https://openalex.org/W2909704566"],"abstract_inverted_index":{"9000":[0],"Background:":[1],"The":[2,256],"third":[3,49],"generation":[4,50],"EGFR":[5,26,51,161],"tyrosine":[6],"kinase":[7],"inhibitor":[8],"(TKI)":[9],"rociletinib":[10,46,227,235],"has":[11],"demonstrated":[12],"activity":[13],"in":[14,98,128,141,153,160,163,170,186,274],"non-small":[15],"cell":[16],"lung":[17],"cancer":[18],"(NSCLC)":[19],"patients":[20],"(pts)":[21],"who":[22],"progressed":[23],"on":[24],"prior":[25],"TKIs":[27],"due":[28],"to":[29,39,45,68,77,82,234,254,291,302],"an":[30,167],"acquired":[31,75],"T790M":[32,199],"resistance":[33,44,76,115,137,194,252,263,290],"mutation.":[34],"Additional":[35],"work":[36],"is":[37],"needed":[38],"understand":[40],"the":[41,99,178,243,268],"mechanisms":[42,71,138,195,253,264],"of":[43,72,85,143,146,183,188,193,258,271,289,299],"and":[47,74,105,132,166,200,208,250,294],"other":[48],"TKIs.":[52],"Methods:":[53],"We":[54,247],"employed":[55],"circulating":[56],"tumor":[57,133,272],"DNA":[58],"analysis":[59,285],"using":[60,283],"Cancer":[61],"Personalized":[62],"Profiling":[63],"by":[64,239],"deep":[65],"Sequencing":[66],"(CAPP-Seq)":[67],"study":[69],"putative":[70],"innate":[73],"rociletinib.":[78,255],"CAPP-Seq":[79],"was":[80,116,177],"applied":[81],"a":[83,156],"total":[84],"115":[86],"serial":[87],"plasma":[88],"samples":[89],"from":[90],"T790M-positive":[91],"NSCLC":[92],"pts":[93],"(n":[94,101,107],"=":[95,102,108],"43)":[96],"enrolled":[97],"TIGER-X":[100],"42)":[103],"(NCT01526928)":[104],"TIGER-2":[106],"1)":[109],"(NCT02147990)":[110],"clinical":[111,221,269],"trials.":[112],"Results:":[113],"Rociletinib":[114],"diverse,":[117],"with":[118,191,219,226,242,261],"mutations":[119,152],"and/or":[120],"copy":[121,175,203],"number":[122,176],"gains":[123],"affecting":[124],"9":[125],"genes":[126],"involved":[127],"bypass":[129],"pathway":[130],"activation":[131],"suppressor":[134],"pathways.":[135],"Multiple":[136],"were":[139],"observed":[140,181,248],"23%":[142],"pts.":[144,276],"Examples":[145],"emergent":[147],"alterations":[148],"included":[149],"activating":[150],"KRAS":[151],"three":[154],"pts,":[155],"novel":[157],"tertiary":[158],"mutation":[159,169],"(L798I)":[162],"one":[164,171],"patient,":[165],"EGFRC797S":[168],"patient.":[172],"Increased":[173],"MET":[174,202,230],"most":[179],"frequently":[180],"mechanism":[182],"resistance,":[184],"occurring":[185],"26%":[187],"cases.":[189],"Pts":[190],"heterogeneity":[192,273],"at":[196,265],"baseline":[197,266],"(both":[198],"increased":[201],"number)":[204],"displayed":[205],"inferior":[206,259],"responses":[207],"significantly":[209],"shorter":[210],"progression":[211],"free":[212],"survival":[213],"(P":[214],"<":[215],"0.05).":[216],"In":[217],"agreement":[218],"these":[220,275],"findings,":[222],"erlotinib-resistant":[223],"xenografts":[224],"treated":[225],"reproducibly":[228],"developed":[229],"amplification.":[231],"Importantly,":[232],"sensitivity":[233],"could":[236],"be":[237],"reinstated":[238],"combined":[240],"therapy":[241],"METinhibitor":[244],"crizotinib.":[245],"Conclusions:":[246],"diverse":[249],"heterogeneous":[251],"association":[257],"outcomes":[260],"multiple":[262],"emphasizes":[267],"importance":[270],"Our":[277],"results":[278],"demonstrate":[279],"that":[280],"non-invasive":[281],"profiling":[282],"ctDNA":[284],"can":[286],"define":[287],"patterns":[288],"targeted":[292],"therapies":[293,301],"potentially":[295],"allows":[296],"for":[297],"personalization":[298],"combination":[300],"overcome":[303],"resistance.":[304]},"counts_by_year":[{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2025-10-10T00:00:00"}